NasdaqCM - Nasdaq Real Time Price USD
Psyence Biomedical Ltd. (PBMWW)
0.0148
+0.0044
+(42.31%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
Operating Cash Flow
-2,873.1070
-2,945.3670
-1,592.0800
-1,396.4220
Investing Cash Flow
-12.1550
-5.7270
--
-32.0395
Financing Cash Flow
4,212.2990
2,350
1,172.9230
-1,627.5764
End Cash Position
1,932.5190
733.1880
1,334.2800
1,755.0382
Capital Expenditure
--
-5.7270
--
--
Issuance of Debt
2,785.0680
2,500
--
--
Repayment of Debt
--
-150
--
--
Free Cash Flow
-2,885.2620
-2,951.0940
-1,592.0800
-1,396.4220
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
PSYBF PsyBio Therapeutics Corp.
0.0001
0.00%
REVBW Revelation Biosciences, Inc.
0.0157
+4.67%
DNABW Ginkgo Bioworks Holdings, Inc.
0.0071
-4.05%
HEMO.L Hemogenyx Pharmaceuticals Plc
185.00
-0.13%
OMGAQ Omega Therapeutics, Inc.
0.0470
+42.42%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
688238.SS Obio Technology (Shanghai) Corp., Ltd.
5.79
-0.69%
PXMD PaxMedica, Inc.
0.0001
0.00%
VXLLF Vaxil Bio Ltd.
0.0129
0.00%